Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Fortress Biotech (FBIO) EBT Margin (2016 - 2025)

Fortress Biotech (FBIO) has 12 years of EBT Margin data on record, last reported at 34.69% in Q3 2025.

  • For Q3 2025, EBT Margin rose 14731.0% year-over-year to 34.69%; the TTM value through Sep 2025 reached 1561.98%, up 282899.0%, while the annual FY2024 figure was 8036.2%, 509810.0% down from the prior year.
  • EBT Margin reached 34.69% in Q3 2025 per FBIO's latest filing, up from 218.43% in the prior quarter.
  • Across five years, EBT Margin topped out at 71.75% in Q4 2023 and bottomed at 8800.0% in Q2 2022.
  • Average EBT Margin over 5 years is 658.28%, with a median of 236.14% recorded in 2021.
  • Peak YoY movement for EBT Margin: tumbled -856063bps in 2022, then surged 851535bps in 2023.
  • A 5-year view of EBT Margin shows it stood at 338.46% in 2021, then decreased by -3bps to 347.45% in 2022, then soared by 121bps to 71.75% in 2023, then fell by -21bps to 56.83% in 2024, then tumbled by -161bps to 34.69% in 2025.
  • Per Business Quant database, its latest 3 readings for EBT Margin were 34.69% in Q3 2025, 218.43% in Q2 2025, and 166.12% in Q1 2025.